Huarui Lu
Impact in
- Toxicology top 10%
Papers in
-
- DNA Repair Mechanisms 5
- Epigenetics and DNA Methylation 4
- Cancer therapeutics and mechanisms 3
- Ubiquitin and proteasome pathways 3
- Oncology 8
- Cancer-related Molecular Pathways 4
- PARP inhibition in cancer therapy 2
- Co-authors
- Haojie Huang (2 shared papers)Timothy C. Hallstrom (10 shared papers)Colleen L. Forster (6 shared papers)Min Huang (2 shared papers)Hong Zhu (2 shared papers)Jian Ding (2 shared papers)Ze‐Hong Miao (2 shared papers)Yi Chen (1 shared paper)
- Journals
- Cell Cycle (3 papers)Cancer Research (3 papers)Oncotarget (2 papers)PLoS ONE (2 papers)Molecular Pharmacology (1 paper)
- Partner nations
- United StatesChina
In The Last Decade
Huarui Lu
18 papers receiving 425 citations
Peers
Comparison fields: 5 of 67
- Toxicology 31
- Cancer Research 76
- Molecular Biology 340
- Oncology 115
- Ophthalmology 35
Countries citing papers authored by Huarui Lu
This map shows the geographic impact of Huarui Lu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Huarui Lu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Huarui Lu more than expected).
Fields of papers citing papers by Huarui Lu
This network shows the impact of papers produced by Huarui Lu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Huarui Lu. The network helps show where Huarui Lu may publish in the future.
Co-authors
The 25 scholars most cited alongside Huarui Lu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2011 | 74 | |
| 2 | 2005 | 65 | |
| 3 | 2005 | 43 | |
| 4 | 2015 | 32 | |
| 5 | 2013 | 27 | |
| 6 | 2004 | 24 | |
| 7 | 2011 | 24 | |
| 8 | 2017 | 21 | |
| 9 | 2011 | 19 | |
| 10 | 2016 | 18 | |
| 11 | 2012 | 17 | |
| 12 | 2006 | 16 | |
| 13 | 2015 | 14 | |
| 14 | 2011 | 12 | |
| 15 | 2022 | 10 | |
| 16 | 2021 | 7 | |
| 17 | 2021 | 4 | |
| 18 | 2024 | 1 | |
| 19 | 2022 | 0 |
About Huarui Lu
Huarui Lu is a scholar working on Molecular Biology, Oncology, Ophthalmology, Genetics and Immunology, having authored 19 papers that have together received 428 indexed citations. Recurring topics across this work include DNA Repair Mechanisms (5 papers), Epigenetics and DNA Methylation (4 papers), Cancer-related Molecular Pathways (4 papers), Cancer therapeutics and mechanisms (3 papers), Ocular Oncology and Treatments (3 papers), Ubiquitin and proteasome pathways (3 papers), PARP inhibition in cancer therapy (2 papers) and Bioactive Compounds and Antitumor Agents (2 papers). The work is most often cited by research in Toxicology (31 citations), Cancer Research (76 citations), Molecular Biology (340 citations), Oncology (115 citations) and Ophthalmology (35 citations). Huarui Lu has collaborated with scholars based in United States and China. Frequent co-authors include Haojie Huang, Timothy C. Hallstrom, Colleen L. Forster, Min Huang, Hong Zhu, Jian Ding, Ze‐Hong Miao, Yi Chen, Yujun Cai and Jin‐Sheng Zhang. Their work appears in journals such as Cell Cycle, Cancer Research, Oncotarget, PLoS ONE and Molecular Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.